Groupe d'Etude en Oncologie du Quebec

Title	The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
Protocole ID	NCI M4
ClinicalTrials.gov ID	NCT03421132
Cancer Type(s)	Myeloma
Phase	Other
Stage	Multiple myeloma
Study Type
Drug
Institution	CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX 5415 boul. de l'Assomption, Montréal, QC, H1T2M4
City	Montréal
Principal Investigator	Dr. Richard Leblanc
Coordinator	Nathalie Lachapelle 514-252-3400 poste 4471
Status	Recruiting
Activation Date	11-09-2018
Eligibility Criteria	Ability to give informed consent Diagnosed with active multiple myeloma Consented to participation in Myeloma Canada Research Network (MCRN) database project Previously untreated and eligible for autologous stem-cell transplantation (ASCT)
Exclusion Criteria	Ineligible for ASCT Does not consent to participate in MCRN database project

Groupe d'étude en oncologie du Québec